Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm, Residual × Anti-Inflammatory Agents, Non-Steroidal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 3 Pain, Postoperative 2 Pain 2 Lung Neoplasms 2 Colonic Neoplasms 2 Agnosia 2 Uterine Cervical Neoplasms 1 Spondylitis, Ankylosing 1 Pituitary Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Mucositis 1 Lymphoma, Follicular 1 Inflammation 1 Endometrial Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1 Anastomotic Leak 1 Adenocarcinoma of Lung 1 Acute Pain 1

Interventions

Cyclophosphamide 19 Cytarabine 13 fludarabine 12 blinatumomab 11 Azacitidine 10 venetoclax 9 fludarabine phosphate 8 Blood Specimen Collection 8 Methotrexate 7 Dexamethasone 7 Lenalidomide 6 Daunorubicin 6 Vincristine 5 Rituximab 5 Mercaptopurine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Etoposide 4 obinutuzumab 3 Liquid Biopsy 3 Idarubicin 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Chemotherapy, Adjuvant 3 Busulfan 3 Asparaginase 3 trastuzumab deruxtecan 2 tislelizumab 2 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03330769 2019-04-17

UPSTREAM

University of Cagliari

Arthritis, Psoriatic, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡